·         To continue our surveillance programme for equine influenza.

 

·         To expand the surveillance programme to other viruses for example, equine herpesviruses and viruses of emerging significance.

 

·         To characterise all influenza and herpesviruses isolated.

 

·         To prepare reference antisera against epidemiologically relevant influenza viruses for distribution to other laboratories.

 

·         To continue to monitor dogs for interspecies transmission of equine influenza.

 

·         To conduct independent comparative vaccine studies.

 

·         To evaluate new diagnostic kits.